BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 12, 2007
View Archived Issues
Pharmacokinetics of GSK-221149A studied to prepare for clinical trial
Read More
C-reactive protein, neopterin correlate with PRTX-100 dose in healthy subjects
Read More
Antiinflammatory effects of the GABA-B agonist baclofen shown in mice
Read More
Recent Abbott patents describe new ACC inhibitors
Read More
Novel chemokine CCR5 receptor antagonists emerge from Roche R&D
Read More
Recent Bayer patent describes new agents for thromboembolic disorders
Read More
Alpharma obtains U.S. rights to Diractin from IDEA
Read More
Power3 Medical Products reports preliminary results of international validation study of PD test
Read More
Iomai begins phase I/II trial of immunostimulant patch with H5N1 influenza vaccine
Read More
Series C financing to fund Trophos' TRO-19622 and TRO-40303
Read More
Update on Pozen and AstraZeneca's PN-400 program
Read More
NeuroSearch begins phase II study of ABT-894 for neuropathic pain
Read More
Spectrum begins enrolling patients in second pivotal phase III trial of EOquin
Read More
OSI Prosidion reports results from metformin and PSN-9301 interaction study
Read More
IL-22 blockade shows benefit in mouse model of rheumatoid arthritis
Read More
Positive first-in-human trial results of novel endothelin antagonist from Actelion
Read More
Lilly launches Cialis for erectile dysfunction in Japan
Read More
Innogenetics to discontinue investment in candidate HCV E1 vaccine
Read More
Affymetrix enters into licensing agreement with Empire Genomics
Read More
Penwest and Otsuka enter into R&D agreement
Read More
FDA approves Adventrx clinical development plan for ANX-514
Read More
XTL Biopharmaceuticals begins phase IIb trial of bicifadine for diabetic neuropathic pain
Read More
Enrollment begins for CeNeS and Ergomed's phase II trial of CNS-5161 for cancer pain
Read More
Moberg Derma initiates enrollment of phase III trial of K-101 for onychomycosis
Read More
